Following on from the wonderful It Takes Two, developer Hazelight took things to the next level when it comes to scale in Split Fiction and continued to hone its craft as the modern-day masters of the ...

2025 was a banner year for action games. From a surprise breakout Soulslike with one of the hardest-hitting and most brutal combat systems the genre has ever seen, to the hotly anticipated follow-up ...

Bristol Myers BMY has a broad oncology portfolio, which includes blockbuster immuno-oncology drugs, Opdivo, Opdivo Qvantig and Yervoy, among others. Among these, Opdivo (nivolumab) is the top revenue ...

Bristol Myers Squibb has won Food and Drug Administration priority review for its application seeking expanded approval of its blockbuster cancer drug Opdivo, in combination with chemotherapy, in ...

Whether it's extra-terrestrial invaders or a nightmare of our own creation, sci-fi often calls us to action. When you purchase through links on our site, we may earn an affiliate commission. Here’s ...

Ryan Heffernan is a Senior Writer at Collider. Storytelling has been one of his interests since an early age, with his appreciation for film and television becoming a particular interest of his during ...

DJI may be the big dog in drones, but it plays third fiddle to GoPro and Insta360 in the action cam market. To better stand out, the company has launched the Osmo Action 6 with a pair of innovative ...

DJI has released its third action cam in less than four months, the Osmo Action 6. The new GoPro rival offers something we've never seen in this type of camera: a variable aperture for more control ...

Oct 30 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab beat Wall Street estimates for third-quarter revenue on Thursday, as strong growth of its cancer immunotherapy and blood thinner Eliquis ...

Watch the No Kings rally live in Washington, D.C., where ACLU staff and our partners will be speaking soon. Good morning. Today’s the day — communities across the country are hitting the streets for ...